Institutions · Entity Annotation Prototype (beta)

2articles mentioning institutions

3institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: Istituto Ortopedico Rizzoli ×

Istituto Ortopedico Rizzoli

This institution is selected. Its supporting articles are shown below.

Istituto Ortopedico Rizzoli2

Articles mentioning Istituto Ortopedico Rizzoli

2 articles · page 1 of 1

Multifactorial strategies for the prevention of the risks of ulceration in patients affected by diabetic foot: a no-profit, multicentre, clinical trial protocol

bmjopen · abstract · 2026-06-19 · 2 matching annotations

90.1%

Istituto Ortopedico Rizzoli UO Piede Diabetico diabetes mellitus diabetic foot

…C n° 476/2024/Sper/IOR, Principal Investigator Prof Lisa Berti, Istituto Ortopedico Rizzoli.CE-AVEC n° 105/Sper/2025/AOUBo, Principal Investigator Prof Ube…

Matrix-directed therapy losartan to identify the effect on the bone resorption marker carboxy-terminal crosslink of type I collagen telopeptide (CTX) in older adolescents and adults with osteogenesis imperfecta recruited from secondary care sites: the ‘MOI-A’ study; a randomised, phase 2/pilot, dose-escalating trial

bmjopen · abstract · 2025-12-07 · 1 matching annotations

78.9%

Istituto di Ricovero e Cura a Carattere Scientifico London Bridge Research Ethics Committee Sheffield Children’s National Health Service Foundation Trust Istituto Ortopedico Rizzoli losartan Osteogenesis imperfecta (OI)sarcopenia EQ-5D OI-QOL

…ld Children’s National Health Service Foundation Trust (UK) and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Ortopedico Rizzoli (Italy) are the joint study…

Browse institutions

Istituto Ortopedico Rizzoli

Articles mentioning Istituto Ortopedico Rizzoli

Multifactorial strategies for the prevention of the risks of ulceration in patients affected by diabetic foot: a no-profit, multicentre, clinical trial protocol